Literature DB >> 16210539

EGFR activation mediates inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycans.

Vuk Koprivica1, Kin-Sang Cho, Jong Bae Park, Glenn Yiu, Jasvinder Atwal, Bryan Gore, Jieun A Kim, Estelle Lin, Marc Tessier-Lavigne, Dong Feng Chen, Zhigang He.   

Abstract

Inhibitory molecules associated with myelin and the glial scar limit axon regeneration in the adult central nervous system (CNS), but the underlying signaling mechanisms of regeneration inhibition are not fully understood. Here, we show that suppressing the kinase function of the epidermal growth factor receptor (EGFR) blocks the activities of both myelin inhibitors and chondroitin sulfate proteoglycans in inhibiting neurite outgrowth. In addition, regeneration inhibitors trigger the phosphorylation of EGFR in a calcium-dependent manner. Local administration of EGFR inhibitors promotes significant regeneration of injured optic nerve fibers, pointing to a promising therapeutic avenue for enhancing axon regeneration after CNS injury.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16210539     DOI: 10.1126/science.1115462

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  125 in total

1.  Nanoparticle-mediated signaling endosome localization regulates growth cone motility and neurite growth.

Authors:  Michael B Steketee; Stavros N Moysidis; Xiao-Lu Jin; Jessica E Weinstein; Wolfgang Pita-Thomas; Hemalatha B Raju; Siraj Iqbal; Jeffrey L Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

Review 2.  Reactive astrogliosis after spinal cord injury-beneficial and detrimental effects.

Authors:  Soheila Karimi-Abdolrezaee; Rohini Billakanti
Journal:  Mol Neurobiol       Date:  2012-06-09       Impact factor: 5.590

Review 3.  Lectican proteoglycans, their cleaving metalloproteinases, and plasticity in the central nervous system extracellular microenvironment.

Authors:  M D Howell; P E Gottschall
Journal:  Neuroscience       Date:  2012-05-22       Impact factor: 3.590

Review 4.  New Insights into the Roles of Nogo-A in CNS Biology and Diseases.

Authors:  Yun-Peng Sui; Xiao-Xi Zhang; Jun-Lin Lu; Feng Sui
Journal:  Neurochem Res       Date:  2015-08-13       Impact factor: 3.996

5.  Long noncoding RNA HOTAIR promotes invasion of breast cancer cells through chondroitin sulfotransferase CHST15.

Authors:  Liang-Chih Liu; Yuan-Liang Wang; Pei-Le Lin; Xiang Zhang; Wei-Chung Cheng; Shu-Hsuan Liu; Chih-Jung Chen; Yu Hung; Chia-Ing Jan; Ling-Chu Chang; Xiaoyang Qi; Linda C Hsieh-Wilson; Shao-Chun Wang
Journal:  Int J Cancer       Date:  2019-04-26       Impact factor: 7.396

6.  Sugar-dependent modulation of neuronal development, regeneration, and plasticity by chondroitin sulfate proteoglycans.

Authors:  Gregory M Miller; Linda C Hsieh-Wilson
Journal:  Exp Neurol       Date:  2015-08-24       Impact factor: 5.330

Review 7.  Glial inhibition of CNS axon regeneration.

Authors:  Glenn Yiu; Zhigang He
Journal:  Nat Rev Neurosci       Date:  2006-08       Impact factor: 34.870

8.  The Rheb-mTOR pathway is upregulated in reactive astrocytes of the injured spinal cord.

Authors:  Simone Codeluppi; Camilla I Svensson; Michael P Hefferan; Fatima Valencia; Morgan D Silldorff; Masakatsu Oshiro; Martin Marsala; Elena B Pasquale
Journal:  J Neurosci       Date:  2009-01-28       Impact factor: 6.167

9.  Identification of a novel antagonist of the ErbB1 receptor capable of inhibiting migration of human glioblastoma cells.

Authors:  Mikkel Staberg; Christian Riemer; Ruodan Xu; Oksana Dmytriyeva; Elisabeth Bock; Vladimir Berezin
Journal:  Cell Oncol (Dordr)       Date:  2013-04-12       Impact factor: 6.730

10.  Comparison of sensory neuron growth cone and filopodial responses to structurally diverse aggrecan variants, in vitro.

Authors:  Justin A Beller; Brandon Kulengowski; Edward M Kobraei; Gabrielle Curinga; Christopher M Calulot; Azita Bahrami; Thomas M Hering; Diane M Snow
Journal:  Exp Neurol       Date:  2013-03-01       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.